ERBB2 and cancer: Despite the effectiveness of TZB in treating HER2-positive cancers, this potentially life-threatening side effect highlights the need for clinicians and regulators to stay informed about the evolving safety profiles of medications to ensure monitoring and early detection to mitigate the risk of permanent heart damage.